ATE249224T1 - Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe - Google Patents
Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabeInfo
- Publication number
- ATE249224T1 ATE249224T1 AT95923502T AT95923502T ATE249224T1 AT E249224 T1 ATE249224 T1 AT E249224T1 AT 95923502 T AT95923502 T AT 95923502T AT 95923502 T AT95923502 T AT 95923502T AT E249224 T1 ATE249224 T1 AT E249224T1
- Authority
- AT
- Austria
- Prior art keywords
- amount
- product containing
- delayed release
- medicinal product
- release medicinal
- Prior art date
Links
- 239000004100 Oxytetracycline Substances 0.000 title 1
- 230000003111 delayed effect Effects 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 title 1
- 229960000625 oxytetracycline Drugs 0.000 title 1
- 235000019366 oxytetracycline Nutrition 0.000 title 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001627 detrimental effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 229940074076 glycerol formal Drugs 0.000 abstract 1
- 239000007972 injectable composition Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 150000002681 magnesium compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
- 239000003002 pH adjusting agent Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- -1 tetracycline compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9413873A GB9413873D0 (en) | 1994-07-09 | 1994-07-09 | Long-acting oxytetracycline composition |
| PCT/GB1995/001583 WO1996001634A1 (en) | 1994-07-09 | 1995-07-05 | Long-acting oxytetracycline composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE249224T1 true ATE249224T1 (de) | 2003-09-15 |
Family
ID=10758078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95923502T ATE249224T1 (de) | 1994-07-09 | 1995-07-05 | Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0769951B1 (de) |
| JP (2) | JP4025925B2 (de) |
| CN (1) | CN1081461C (de) |
| AT (1) | ATE249224T1 (de) |
| AU (1) | AU707366B2 (de) |
| DE (1) | DE69531736T2 (de) |
| DK (1) | DK0769951T3 (de) |
| ES (1) | ES2204958T3 (de) |
| GB (1) | GB9413873D0 (de) |
| MX (1) | MX9700287A (de) |
| NZ (1) | NZ288717A (de) |
| PT (1) | PT769951E (de) |
| WO (1) | WO1996001634A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2130069B1 (es) * | 1997-04-10 | 2000-03-01 | Basf Labiana S A | Preparacion farmaceutica con liberacion retardada del producto activo. |
| DK0980248T3 (da) * | 1997-05-06 | 2001-11-19 | Norbrook Lab Ltd | Forbedringer af eller vedrørende langtidsvirkende antibiotika |
| US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
| GB9928343D0 (en) * | 1999-11-30 | 2000-01-26 | Vericore Ltd | Addition of tetracyclines to animal foodstuffs |
| US6428975B1 (en) * | 2000-01-14 | 2002-08-06 | Blue Ridge Pharmaceuticals, Inc. | Methods for determining the presence or absence of microorganisms in lipid-containing compositions |
| RU2178698C1 (ru) * | 2000-11-28 | 2002-01-27 | Закрытое Акционерное Общество "Нита-Фарм" | Способ получения композиции магниевого комплекса окситетрациклина пролонгированного действия |
| NO20014746D0 (no) | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
| ES2315123B1 (es) * | 2006-09-25 | 2009-12-30 | Divasa-Farmavic, S.A. | Composiciones farmaceuticas estables de tetraciclinas en solucion, procedimiento para su obtencion y sus usos. |
| EP3135289B1 (de) | 2010-05-12 | 2018-12-12 | Rempex Pharmaceuticals, Inc. | Tetracyclinzusammensetzungen |
| CN103271238B (zh) * | 2013-05-10 | 2014-04-02 | 中国科学院亚热带农业生态研究所 | 一种饲料添加剂一乙醇胺的制备方法及应用 |
| CN106309357A (zh) * | 2016-11-08 | 2017-01-11 | 河南益华动物药业有限公司 | 兽用盐酸土霉素凝胶植入剂及其制备方法 |
| CN110693826A (zh) * | 2019-11-18 | 2020-01-17 | 成都新亨药业有限公司 | 一种兽用长效土霉素注射液及其制备方法 |
| CN111035614B (zh) * | 2019-12-20 | 2024-02-02 | 北京喜禽药业有限公司 | 一种高含量土霉素注射液及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL141086B (nl) * | 1969-03-13 | 1974-02-15 | Diamond Shamrock Corp | Werkwijze voor het bereiden van een voor parenterale toediening geschikt oxytetracyclinepreparaat. |
| DE2001604C2 (de) * | 1970-01-15 | 1983-04-14 | Pfizer Gmbh, 7500 Karlsruhe | Verwendung von Polyäthylenglykol zur Herstellung von Oxytetracyclinlösungen zur parenteralen, peroralen und lokalen Anwendung |
| US4259331A (en) * | 1979-04-16 | 1981-03-31 | Pfizer Inc. | Oxytetracycline compositions |
| CA1163197A (en) * | 1980-04-10 | 1984-03-06 | Herman Horn | Injectable oxytetracycline compositions |
| NL178941C (nl) * | 1982-06-15 | 1986-06-16 | Aesculaap Bv | Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat. |
| IE74244B1 (en) * | 1985-10-01 | 1997-07-16 | Bimeda Res Dev Ltd | A process for preparing an antibiotic composition |
| US5075295A (en) * | 1989-12-12 | 1991-12-24 | Boehringer Ingelheim Animal Health, Inc. | Novel oxytetracycline compositions |
-
1994
- 1994-07-09 GB GB9413873A patent/GB9413873D0/en active Pending
-
1995
- 1995-07-05 JP JP50417996A patent/JP4025925B2/ja not_active Expired - Lifetime
- 1995-07-05 PT PT95923502T patent/PT769951E/pt unknown
- 1995-07-05 NZ NZ288717A patent/NZ288717A/en not_active IP Right Cessation
- 1995-07-05 WO PCT/GB1995/001583 patent/WO1996001634A1/en not_active Ceased
- 1995-07-05 DE DE69531736T patent/DE69531736T2/de not_active Expired - Lifetime
- 1995-07-05 AU AU28043/95A patent/AU707366B2/en not_active Expired
- 1995-07-05 CN CN95194645A patent/CN1081461C/zh not_active Expired - Fee Related
- 1995-07-05 ES ES95923502T patent/ES2204958T3/es not_active Expired - Lifetime
- 1995-07-05 EP EP95923502A patent/EP0769951B1/de not_active Expired - Lifetime
- 1995-07-05 AT AT95923502T patent/ATE249224T1/de active
- 1995-07-05 DK DK95923502T patent/DK0769951T3/da active
-
1997
- 1997-01-09 MX MX9700287A patent/MX9700287A/es active IP Right Grant
-
2007
- 2007-08-08 JP JP2007206510A patent/JP4804431B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996001634A1 (en) | 1996-01-25 |
| DE69531736D1 (de) | 2003-10-16 |
| JP4804431B2 (ja) | 2011-11-02 |
| JPH10502628A (ja) | 1998-03-10 |
| EP0769951B1 (de) | 2003-09-10 |
| AU2804395A (en) | 1996-02-09 |
| CN1081461C (zh) | 2002-03-27 |
| NZ288717A (en) | 1998-02-26 |
| DK0769951T3 (da) | 2004-01-12 |
| AU707366B2 (en) | 1999-07-08 |
| MX9700287A (es) | 1998-10-31 |
| PT769951E (pt) | 2003-12-31 |
| GB9413873D0 (en) | 1994-08-31 |
| ES2204958T3 (es) | 2004-05-01 |
| CN1156963A (zh) | 1997-08-13 |
| EP0769951A1 (de) | 1997-05-02 |
| JP4025925B2 (ja) | 2007-12-26 |
| DE69531736T2 (de) | 2004-07-08 |
| JP2007326875A (ja) | 2007-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG26287A (en) | Fixed solid composition containing pregabalin, glycol or glycerol as moisturizer | |
| ATE249224T1 (de) | Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe | |
| KR850007559A (ko) | 조절 펩타이드의 삽입식 제형 | |
| RU94033520A (ru) | Впрыскиваемый лецитиновый гель | |
| SE7611379L (sv) | Antihypertensiva medel | |
| ES8608875A1 (es) | Un metodo para preparar una composicion farmaceutica para aplicacion topica que contiene 1-dodecilazacicloheptan-2-ona. | |
| ES2173400T3 (es) | Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido. | |
| BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
| FI962111A0 (fi) | Mikrokapseloidut 3-piperidinyyli-substituoidut 1,2-bentsisoksatsolit ja 1,2-bentsisotiatsolit | |
| KR920012113A (ko) | 펩타이드 유도체의 사용방법 | |
| MX9305146A (es) | Conjugado de interferon, procedimiento para su preracion y composicion farmaceutica que lo contienen. | |
| RU95112575A (ru) | Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция | |
| ES2171933T3 (es) | Derivados de androsteno. | |
| ATE220321T1 (de) | Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe | |
| ATE228005T1 (de) | Pharmazeutische formulierungen aus corticotropin freisetzenden faktor mit verbesserter stabilitaet in fluessiger form | |
| FI940696A0 (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
| RU95100770A (ru) | Противовоспалительные композиции местного применения, содержащие пироксикам, способ солюбилизации пироксикама | |
| ES2028917T3 (es) | Un procedimiento para preparar una composicion farmaceutica inyectable estable. | |
| WO1996001634B1 (en) | Long-acting oxytetracycline composition | |
| LV11818A (lv) | Jauna farmaceitiska kompozicija stabilas pulverveida zalu formas pagatavosanai | |
| ATE59554T1 (de) | Auf mercaptoethansulfonsaeuren basierende pharmazeutische zusammensetzungen, organische abkoemmlinge von mercaptoethansulfonsaeuren sowie verfahren zu deren herstellung. | |
| JPS5651410A (en) | Ointment | |
| CA2194576A1 (en) | Long-acting oxytetracycline composition | |
| JPS5750914A (en) | Betamethasone external pharmaceutical | |
| DK0893121T3 (da) | Flydende oral medicinopløsning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0769951 Country of ref document: EP |